blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP3773577

EP3773577 - TRICYCLIC ASK1 INHIBITORS [Right-click to bookmark this link]
StatusGrant of patent is intended
Status updated on  17.06.2024
Database last updated on 05.10.2024
FormerExamination is in progress
Status updated on  27.04.2023
FormerRequest for examination was made
Status updated on  15.01.2021
FormerThe international publication has been made
Status updated on  19.10.2019
Most recent event   Tooltip17.06.2024New entry: Communication of intention to grant a patent 
Applicant(s)For all designated states
Terns, Inc.
1065 E. Hillsdale Blvd.
Suite 100
Foster City, California 94404 / US
[2021/07]
Inventor(s)01 / XU, Yingzi
1065 E. Hillsdale Blvd., Suite 100
Foster City, California 94404 / US
02 / HALCOMB, Randall
1065 E. Hillsdale Blvd., Suite 100
Foster City, California 94404 / US
03 / KIRSCHBERG, Thorsten A.
1065 E. Hillsdale Blvd., Suite 100
Foster City, California 94404 / US
04 / ROMERO, F. Anthony
1065 E. Hillsdale Blvd., Suite 100
Foster City, California 94404 / US
 [2021/07]
Representative(s)Mewburn Ellis LLP
Aurora Building
Counterslip
Bristol BS1 6BX / GB
[N/P]
Former [2021/07]Mewburn Ellis LLP
Aurora Building
Counterslip
Bristol BS1 6BX / GB
Application number, filing date19786244.412.04.2019
[2021/07]
WO2019US27236
Priority number, dateUS201862656764P12.04.2018         Original published format: US 201862656764 P
US201862720863P21.08.2018         Original published format: US 201862720863 P
[2021/07]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2019200267
Date:17.10.2019
Language:EN
[2019/42]
Type: A1 Application with search report 
No.:EP3773577
Date:17.02.2021
Language:EN
The application published by WIPO in one of the EPO official languages on 17.10.2019 takes the place of the publication of the European patent application.
[2021/07]
Search report(s)International search report - published on:US17.10.2019
(Supplementary) European search report - dispatched on:EP03.11.2021
ClassificationIPC:C07D498/04, C07D498/10, C07D519/00, A61K31/444, A61K31/506, A61P1/16, A61P9/04, A61P9/12, A61P13/12, A61P25/28, A61P29/00
[2024/28]
CPC:
A61P1/16 (EP,US); C07D498/04 (EP,US); A61P13/12 (EP,US);
A61P25/28 (EP,US); A61P29/00 (EP,US); A61P9/04 (EP,US);
A61P9/12 (EP,US); C07D498/10 (EP); C07D519/00 (EP) (-)
Former IPC [2021/48]C07D498/04, C07D498/10, C07D519/00, A61K31/444, A61K31/506
Former IPC [2021/07]A61K31/444, A61K31/506, C07D401/14
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2021/07]
TitleGerman:TRICYCLISCHE ASK1-INHIBITOREN[2021/07]
English:TRICYCLIC ASK1 INHIBITORS[2021/07]
French:INHIBITEURS D'ASK1 TRICYCLIQUES[2021/07]
Entry into regional phase11.11.2020National basic fee paid 
11.11.2020Search fee paid 
11.11.2020Designation fee(s) paid 
11.11.2020Examination fee paid 
Examination procedure11.11.2020Examination requested  [2021/07]
01.06.2022Amendment by applicant (claims and/or description)
26.04.2023Despatch of a communication from the examining division (Time limit: M06)
01.11.2023Reply to a communication from the examining division
18.06.2024Communication of intention to grant the patent
Fees paidRenewal fee
15.04.2021Renewal fee patent year 03
16.03.2022Renewal fee patent year 04
23.02.2023Renewal fee patent year 05
25.04.2024Renewal fee patent year 06
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:Search[X]JPH11349572  (FUJISAWA PHARMACEUTICAL CO)
International search[A]US2012004267  (CORKEY BRITTON [US], et al) [A] 1-2, 3/1-2, 16-17 * ; paragraphs [0009], [0014], [0016]-[0017] *;
 [A]US2014228411  (NOTTE GREGORY [US]) [A] 1-2, 3/1-2, 16-17 * ; paragraph [0019] *;
 [A]US2016304523  (ALEXANDER RIKKI PETER [GB], et al) [A] 1-2, 3/1-2, 16-17* ; paragraph [0011] *;
 [A]US2017196844  (GRAUPE MICHAEL [US], et al) [A] 1-2, 3/1-2, 16-17 * ; paragraphs [0009]-[0011], [0016]. [0018] *
by applicantUS2012004267
 US2014228411
 US2016304523
 US2017196844
    - ICHIJO et al., Science, (19970000), vol. 275, pages 90 - 94
    - HATTORI et al., Cell Comm. Signal., (20090000), vol. 7, pages 1 - 10
    - TAKEDA et al., Annu. Rev. Pharmacol. Toxicol., (20070000), vol. 48, no. 1-8, page 27
    - NAGAI et al., J. Biochem. Mol., (20070000), vol. 40, pages 1 - 6
    - WATANABE et al., BBRC, (20050000), vol. 333, pages 562 - 567
    - ZHANG et al., Cell Death Dis., (20140000), vol. 5, no. 10, page 467
    - TERADA et al., BBRC, (20070000), vol. 364, pages 1043 - 49
    - SINGH et al., Nat. Rev. Endocrinol., (20110000), vol. 7, no. 3, pages 176 - 184
    - BROWNLEE M., Nature, (20010000), vol. 414, no. 6865, pages 813 - 820
    - MIMURA et al., Nat. Rev., (20100000), vol. 6, no. 1, pages 667 - 678
    - HUNG et al., Am. J. Nephrol., (20090000), vol. 29, no. 3, pages 192 - 202
    - NOGRADY, Medicinal Chemistry A Biochemical Approach, Oxford University Press, (19850000), pages 388 - 392
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.